NCI-H1915(ICGE-NCI-H1915,IC-82484)
Overview
Permits and Restrictions | |
---|---|
Organism | Homo sapiens, human |
Tissue | lung |
Cell Type | large cell |
Product Format | frozen |
Culture Properties | adherent |
Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Disease | stage 4, poorly differentiated carcinoma; non-small cell lung cancer |
Age | 61 years |
Gender | female |
Ethnicity | Caucasian |
Storage Conditions | liquid nitrogen vapor phase |
Properties
Derivation |
The line was established in April 1988.
The line was developed from a brain metastasis (probably from a primary lung carcinoma).
|
---|---|
Clinical Data |
The tissue donor was a non-smoker.
|
Background
Complete Growth Medium |
The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. |
---|---|
Subculturing |
Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.
Subcultivation Ratio: 1:3 to 1:4 Note: For more information on enzymatic dissociation and subculturing of cell lines consult Chapter 10 in Culture of Animal Cells, a Manual of Basic Technique by R. Ian Freshney, 3rd edition, published by Alan R. Liss, N.Y., 1994. |
Cryopreservation |
Culture medium, 95%; DMSO, 5%. Cell culture tested DMSO is available as ATCC Catalog No. 4-X.
|